Structure

InChI Key FBPFZTCFMRRESA-JGWLITMVSA-N
Smile OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
InChI
InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5-,6-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C6H14O6
Molecular Weight 182.17
AlogP -3.59
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 6.0
Number of Rotational Bond 5.0
Polar Surface Area 121.38
Molecular species NEUTRAL
Aromatic Rings 0.0
Heavy Atoms 12.0

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Protease Serine protease Serine protease PA clan Serine protease S1A subfamily
- - - - 38

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Constipation 4 D003248 ClinicalTrials
Charcot-Marie-Tooth Disease 3 D002607 ClinicalTrials
Osteoarthritis 2 D010003 ClinicalTrials
Non-alcoholic Fatty Liver Disease 2 D065626 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials
Pain 1 D010146 ClinicalTrials
Bacterial Infections 1 D001424 ClinicalTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 D015464 ClinicalTrials

Related Entries

Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
50.0
Gastrointestinal disorders
16.67
Injury, poisoning and procedural complications
16.67
Musculoskeletal and connective tissue disorders
16.67

Cross References

Resources Reference
CAS NUMBER 50-70-4
ChEBI 17924
ChEMBL CHEMBL1682
DrugBank DB01638
DrugCentral 2462
EPA CompTox DTXSID5023588
FDA SRS 506T60A25R
Human Metabolome Database HMDB0000247
KEGG C00794
PDB SOR
PharmGKB PA451455
PubChem 5780
SureChEMBL SCHEMBL763
ZINC ZINC000018279893